Worldwide sales and distribution agreement for c-LEcta

Sartorius Stedim Biotech and c-LEcta announce the signing of a worldwide sales and distribution agreement for c-LEcta’s proprietary Serratia marcescens nuclease for biopharmaceutical applications. Serratia marcescens Nuclease from c-LEcta is an endonuclease produced in a genetically engineered Bacillus strain. Endonucleases are used in various biopharmaceutical production processes to optimize the process efficiency by reducing viscosity levels and by removing nucleic acids.